Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10490) 10490
Book / eBook (31) 31
Magazine Article (23) 23
Book Chapter (8) 8
Conference Proceeding (6) 6
Government Document (6) 6
Publication (4) 4
Dissertation (3) 3
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9524) 9524
science & technology (7597) 7597
life sciences & biomedicine (7222) 7222
female (5951) 5951
oncology (4426) 4426
male (3701) 3701
biological and medical sciences (2969) 2969
breast cancer (2923) 2923
animals (2869) 2869
medical sciences (2831) 2831
tumors (2550) 2550
middle aged (2420) 2420
neoplasms, hormone-dependent - drug therapy (2361) 2361
breast neoplasms - drug therapy (2269) 2269
cancer (2212) 2212
aged (1970) 1970
breast neoplasms - pathology (1746) 1746
prostate cancer (1621) 1621
adult (1594) 1594
cell line, tumor (1584) 1584
breast neoplasms - metabolism (1501) 1501
neoplasms, hormone-dependent - pathology (1408) 1408
prostatic neoplasms - drug therapy (1394) 1394
mice (1367) 1367
prostatic neoplasms - pathology (1329) 1329
gynecology. andrology. obstetrics (1259) 1259
research (1200) 1200
antineoplastic agents, hormonal - therapeutic use (1119) 1119
neoplasms, hormone-dependent - metabolism (1086) 1086
care and treatment (1081) 1081
prognosis (1052) 1052
pharmacology. drug treatments (1036) 1036
antineoplastic agents (1002) 1002
chemotherapy (987) 987
breast neoplasms - genetics (957) 957
health aspects (950) 950
risk factors (902) 902
prostatic neoplasms - metabolism (865) 865
medicine & public health (857) 857
mammary gland diseases (822) 822
apoptosis (809) 809
gene expression (794) 794
receptors, estrogen - metabolism (779) 779
estrogens (770) 770
endocrinology & metabolism (766) 766
aged, 80 and over (763) 763
estrogen (761) 761
treatment outcome (759) 759
gene expression regulation, neoplastic (744) 744
neoplasms, hormone-dependent - therapy (730) 730
cell biology (720) 720
analysis (713) 713
antineoplastic agents - therapeutic use (712) 712
signal transduction (707) 707
tamoxifen - therapeutic use (706) 706
tumor cells, cultured (702) 702
metastasis (658) 658
biochemistry & molecular biology (647) 647
research article (645) 645
development and progression (630) 630
genetic aspects (626) 626
prostatic neoplasms - genetics (625) 625
antineoplastic agents - pharmacology (621) 621
cell proliferation - drug effects (614) 614
immunohistochemistry (589) 589
abridged index medicus (580) 580
nephrology. urinary tract diseases (579) 579
neoplasms, hormone-dependent - genetics (574) 574
proteins (572) 572
rats (571) 571
apoptosis - drug effects (566) 566
tumors of the urinary system (564) 564
urinary tract. prostate gland (563) 563
urology & nephrology (555) 555
androgens (547) 547
antineoplastic combined chemotherapy protocols - therapeutic use (540) 540
cell proliferation (537) 537
tamoxifen (534) 534
pharmacology & pharmacy (530) 530
mice, nude (527) 527
medicine (521) 521
neoplasm staging (509) 509
physiological aspects (506) 506
hormones (492) 492
disease progression (487) 487
receptors, androgen - metabolism (483) 483
neoplasm metastasis (472) 472
receptors, estrogen - analysis (463) 463
chemotherapy, adjuvant (448) 448
breast neoplasms - therapy (446) 446
prostatic neoplasms - therapy (443) 443
menopause (435) 435
combined modality therapy (433) 433
cancer therapies (425) 425
drug therapy (422) 422
review (413) 413
postmenopause (411) 411
androgen antagonists - therapeutic use (410) 410
drug resistance, neoplasm (397) 397
breast neoplasms - mortality (396) 396
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10131) 10131
German (158) 158
Japanese (125) 125
French (114) 114
Russian (56) 56
Spanish (50) 50
Italian (32) 32
Chinese (16) 16
Polish (11) 11
Hungarian (9) 9
Portuguese (5) 5
Serbian (5) 5
Croatian (4) 4
Czech (4) 4
Dutch (4) 4
Ukrainian (4) 4
Norwegian (3) 3
Finnish (2) 2
Hebrew (2) 2
Swedish (2) 2
Bulgarian (1) 1
Danish (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Gender‐affirming hormone therapy and the risk of sex hormone‐dependent tumours in transgender individuals—A systematic review
by McFarlane, Thomas and Zajac, Jeffrey D and Cheung, Ada S
Clinical endocrinology (Oxford), ISSN 0300-0664, 12/2018, Volume 89, Issue 6, pp. 700 - 711
transgender persons | testosterone | hormones | review | oestradiol | gender dysphoria | neoplasms | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Estradiol - adverse effects | Transgender Persons - statistics & numerical data | Testosterone - adverse effects | Neoplasms, Hormone-Dependent - etiology | Humans | Testosterone | Transgender people | Oncology, Experimental | Mortality | Research | Gender identity | Cancer | Tumors | Prolactin | Pituitary | Case reports | Endocrine therapy | Systematic review | Adenoma | Transgender persons | Meningioma | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Androgen receptors in hormone-dependent and castration-resistant prostate cancer
by Shafi, Ayesha A and Yen, Aihua E and Weigel, Nancy L
Pharmacology & therapeutics (Oxford), ISSN 0163-7258, 2013, Volume 140, Issue 3, pp. 223 - 238
Castration-resistant prostate cancer | Steroidogenesis | Abiraterone | Prostate | Enzalutamide (MDV3100) | Androgen receptor | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Tumors of the urinary system | Urinary tract. Prostate gland | Gynecology. Andrology. Obstetrics | Nephrology. Urinary tract diseases | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Male genital diseases | Tumors | Androgens - genetics | Animals | Receptors, Androgen - genetics | Humans | Receptors, Androgen - metabolism | Male | Prostatic Neoplasms, Castration-Resistant - drug therapy | Androgens - metabolism | Prostatic Neoplasms, Castration-Resistant - metabolism | Prostatic Neoplasms, Castration-Resistant - genetics | Proteins | Physiological aspects | Hormones, Sex | Prostate cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
by Loi, Sherene and Haibe-Kains, Benjamin and Desmedt, Christine and Wirapati, Pratyaksha and Lallemand, Françoise and Tutt, Andrew M and Gillet, Cheryl and Ellis, Paul and Ryder, Kenneth and Reid, James F and Daidone, Maria G and Pierotti, Marco A and Berns, Els M.J.J and Jansen, Maurice P.H.M and Foekens, John A and Delorenzi, Mauro and Bontempi, Gianluca and Piccart, Martine J and Sotiriou, Christos
BMC genomics, ISSN 1471-2164, 05/2008, Volume 9, Issue 1, pp. 239 - 239
Genetics & Heredity | Life Sciences & Biomedicine | Biotechnology & Applied Microbiology | Science & Technology | Neoplasms, Hormone-Dependent - metabolism | Breast Neoplasms - secondary | Receptors, Estrogen - metabolism | Prognosis | Humans | Databases, Genetic | Neoplasms, Hormone-Dependent - secondary | Breast Neoplasms - drug therapy | Breast Neoplasms - metabolism | Neoplasms, Hormone-Dependent - genetics | Receptors, Progesterone - metabolism | Breast Neoplasms - genetics | Gene Expression Profiling - statistics & numerical data | Antineoplastic Agents, Hormonal - therapeutic use | Tamoxifen - therapeutic use | Female | Chemotherapy, Adjuvant | Neoplasms, Hormone-Dependent - drug therapy | Receptors | Estrogen | Dosage and administration | Breast cancer | Genetic aspects | Research | Tamoxifen | Drug therapy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Polymer Therapeutics Designed for a Combination Therapy of Hormone‐Dependent Cancer
by Vicent, María J and Greco, Francesca and Nicholson, Robert I and Paul, Alison and Griffiths, Peter C and Duncan, Ruth
Angewandte Chemie (International ed.), ISSN 1433-7851, 06/2005, Volume 44, Issue 26, pp. 4061 - 4066
tumor targeting | drug delivery | polymers | drug design | antitumor agents | Drug delivery | Drug design | Antitumor agents | Polymers | Tumor targeting | Physical Sciences | Chemistry | Chemistry, Multidisciplinary | Science & Technology | Aminoglutethimide - pharmacology | Antibiotics, Antineoplastic - pharmacology | Humans | Doxorubicin - chemistry | Methacrylates - chemistry | Aminoglutethimide - analogs & derivatives | Breast Neoplasms - drug therapy | Antibiotics, Antineoplastic - chemistry | Doxorubicin - analogs & derivatives | Drug Design | Polymers - pharmacology | Cell Line, Tumor | Inhibitory Concentration 50 | Methacrylates - pharmacology | Female | Polymers - chemistry | Molecular Structure | Neoplasms, Hormone-Dependent - drug therapy | Drug Therapy, Combination | Aminoglutethimide - chemistry | Doxorubicin - pharmacology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Cardiovascular risk of androgen deprivation therapy for treatment of hormone-dependent prostate cancer. Differences between GnRH antagonists and GnRH agonists
by Tschoepe, C and Kherad, B and Spillmann, F and Schneider, C. A and Pieske, B and Krackhardt, F
Herz, ISSN 0340-9937, 12/2016, Volume 41, Issue 8, pp. 697 - 705
Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Comorbidity | Humans | Middle Aged | Male | Treatment Outcome | Gonadotropin-Releasing Hormone - antagonists & inhibitors | Evidence-Based Medicine | Neoplasms, Hormone-Dependent - epidemiology | Drug-Related Side Effects and Adverse Reactions - epidemiology | Incidence | Prostatic Neoplasms - epidemiology | Aged, 80 and over | Androgen Antagonists - therapeutic use | Cardiovascular Diseases - epidemiology | Adult | Aged | Neoplasms, Hormone-Dependent - drug therapy | Causality | Gonadotropin-Releasing Hormone - agonists | Prostatic Neoplasms - drug therapy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Comorbidities in Australian women with hormone‐dependent breast cancer: a population‐based analysis
by Ng, Huah Shin and Koczwara, Bogda and Roder, David M and Niyonsenga, Theo and Vitry, Agnes I
Medical journal of Australia, ISSN 0025-729X, 01/2018, Volume 208, Issue 1, pp. 24 - 28
General medicine | Neoplasms | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Depression - epidemiology | Comorbidity | Humans | Middle Aged | Chronic Disease - epidemiology | Breast Neoplasms - drug therapy | Australia - epidemiology | Antineoplastic Agents, Hormonal - therapeutic use | Aged, 80 and over | Cardiovascular Diseases - epidemiology | Chronic Disease - classification | Female | Aged | Retrospective Studies | Cohort Studies | Osteoporosis - epidemiology | Cancer patients | Breast cancer | Diagnosis | Demographic aspects | Health aspects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Development of 17β-hydroxysteroid dehydrogenase type 3 as a target in hormone-dependent prostate cancer therapy
by Ning, Xiaohui and Yang, Yan and Deng, Hong and Zhang, Qihao and Huang, Yadong and Su, Zhijian and Fu, Yongmei and Xiang, Qi and Zhang, Shu
Steroids, ISSN 0039-128X, 05/2017, Volume 121, pp. 10 - 16
Testosterone | Hormone-dependent prostate cancer | Inhibitor | 17β-Hydroxysteroid dehydrogenase type 3 | Biochemistry & Molecular Biology | Endocrinology & Metabolism | Life Sciences & Biomedicine | Science & Technology | Prostatic Neoplasms - metabolism | Testosterone - metabolism | 17-Hydroxysteroid Dehydrogenases - antagonists & inhibitors | Humans | Prostatic Neoplasms - enzymology | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - chemistry | 17-Hydroxysteroid Dehydrogenases - metabolism | Prostatic Neoplasms - drug therapy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Role of steroid receptor and coregulator mutations in hormone-dependent cancers
by Groner, Anna C and Brown, Myles
The Journal of clinical investigation, ISSN 0021-9738, 04/2017, Volume 127, Issue 4, pp. 1126 - 1135
Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Receptors, Steroid - metabolism | Humans | Male | Signal Transduction - genetics | Neoplasm Proteins - metabolism | Breast Neoplasms - metabolism | Androgens - genetics | Breast Neoplasms - therapy | Prostatic Neoplasms | Drug Resistance, Neoplasm - genetics | Animals | Breast Neoplasms - genetics | Receptors, Steroid - genetics | Estrogens - genetics | Female | Mutation | Androgens - metabolism | Estrogens - metabolism | Neoplasm Proteins - genetics | Receptors | Gene mutations | Oncology, Experimental | Research | Properties | Health aspects | Steroid hormones | Cancer | Disease | Estrogens | Endocrine therapy | Metastasis | Gene expression | Cancer therapies | Androgens | Womens health | Surgery | Epigenetics | Ligands | Prostate | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights